Verified Nov 2026
Batteries & E-Mobility
·

Stamford, Connecticut
·
Since 2017
SpringWorks Therapeutics is a biopharmaceutical company founded in 2017 and headquartered in Stamford, Connecticut, with 200–500 employees and estimated revenue of $100–250M. The company develops precision medicines for rare diseases, particularly rare tumors and cancers. It is a wholly-owned subsidiary of Merck KGaA. SpringWorks markets OGSIVEO for desmoid tumors and GOMEKLI for neurofibromatosis type 1-associated plexiform neurofibromas, with regulatory approvals in the United States and European markets.
SpringWorks Therapeutics at a glance
Revenue
$100-250M
Est. band
Employees
200-500
Founded
2017
Headquarters
Stamford, Connecticut
Industries
Automotive
Electric Vehicles
Medical
Overview
SpringWorks Therapeutics is a biopharmaceutical company founded in 2017 and headquartered in Stamford, Connecticut, with 200–500 employees and estimated revenue of $100–250M. The company develops precision medicines for rare diseases, particularly rare tumors and cancers. It is a wholly-owned subsidiary of Merck KGaA. SpringWorks markets OGSIVEO for desmoid tumors and GOMEKLI for neurofibromatosis type 1-associated plexiform neurofibromas, with regulatory approvals in the United States and European markets.
At a glance
Attribute | Detail |
|---|---|
Founded | 2017 |
Headquarters | Stamford, Connecticut |
Employees | 200-500 |
Revenue | $100-250M (estimated) |
Primary capability | Batteries & E-Mobility |
What SpringWorks Therapeutics makes
The company offers small molecule targeted oncology therapies with two FDA-approved commercial products and a clinical pipeline of candidates targeting solid tumors and hematological cancers.
Latest developments
2026-03-05 — Springworks therapeutics | Radio Compass News | PharmaCompass.com (pharmacompass.com)
2025-10-21 — Press Releases | SpringWorks Therapeutics (springworkstx.com)
2025-08-12 — Merck KGaA Taps High-Grade Bond Market to Fund SpringWorks Buy - Bloomberg (bloomberg.com)
2025-07-18 — European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN | SpringWorks Therapeutics (springworkstx.com)
2025-07-01 — SpringWorks-acquisiton-completed (emdgroup.com)
2025-04-28 — Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business | SpringWorks Therapeutics (springworkstx.com)
Facilities
SpringWorks Therapeutics is headquartered in Stamford, Connecticut. Public sources also reference these locations:
Darmstadt, Germany — bloomberg.com
Company details
SpringWorks became a subsidiary of Merck KGaA following completion of its acquisition in July 2025. SpringWorks Therapeutics was founded in 2017, has an estimated 200-500 employees, and is headquartered in Stamford, Connecticut.
Frequently asked questions
What does SpringWorks Therapeutics make?
SpringWorks Therapeutics is a biopharmaceutical company founded in 2017 and headquartered in Stamford, Connecticut, with 200–500 employees and estimated revenue of $100–250M. The company develops precision medicines for rare diseases, particularly rare tumors and cancers. It is a wholly-owned subsidiary of Merck KGaA. SpringWorks markets OGSIVEO for desmoid tumors and GOMEKLI for neurofibromatosis type 1-associated plexiform neurofibromas, with regulatory approvals in the United States and European markets.
Where is SpringWorks Therapeutics headquartered?
SpringWorks Therapeutics is headquartered in Stamford, Connecticut (100 Washington Blvd, Stamford, Connecticut, 06902).
When was SpringWorks Therapeutics founded?
SpringWorks Therapeutics was founded in 2017.
How big is SpringWorks Therapeutics?
SpringWorks Therapeutics has an estimated 200-500 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
